Evidence map›Paper›PMID 34377401›Full record

ArticleChemical science2021

Combining flavin photocatalysis with parallel synthesis: a general platform to optimize peptides with non-proteinogenic amino acids.

Jacob R Immel, Maheshwerreddy Chilamari, Steven Bloom

Abstract read
In one paragraph

Article in Chemical science, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Poly-Dha Sequences asJACS Au · 2024
    Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. A Vitamin BAngewandte Chemie (Weinheim an der Bergstrasse, Germany) · 2022
    Article
  14. A Vitamin BAngewandte Chemie (International ed. in English) · 2022
    Article
  15. Article
  16. PeptideACS central science · 2022
    Article
  17. The Impact of Boron Hybridisation on Photocatalytic Processes.Angewandte Chemie (International ed. in English) · 2022
    Review
  18. Article
  19. Article
  20. Photoredox-Catalyzed DecarboxylativeACS chemical biology · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Jacob R ImmelDepartment of Medicinal Chemistry, The University of Kansas Integrated Science Building Lawrence KS 66045 USA spbloom@ku.edu.
Maheshwerreddy ChilamariDepartment of Medicinal Chemistry, The University of Kansas Integrated Science Building Lawrence KS 66045 USA spbloom@ku.edu.
Steven BloomDepartment of Medicinal Chemistry, The University of Kansas Integrated Science Building Lawrence KS 66045 USA spbloom@ku.edu.ORCID https://orcid.org/0000-0002-4205-4459

Funding

Synthetic Chemical Biology CoreP20GM113117 · NIGMS · UNIVERSITY OF KANSAS LAWRENCE · PI OROZCO, ROBIN C. · 2016 to 2025
$23.9M
NIGMS NIH HHS P20 GM113117
6 · The paper itself

Abstract

Most peptide drugs contain non-proteinogenic amino acids (NPAAs), born out through extensive structure-activity relationship (SAR) studies using solid-phase peptide synthesis (SPPS). Synthetically laborious and expensive to manufacture, NPAAs also can have poor coupling efficiencies allowing only a small fraction to be sampled by conventional SPPS. To gain general access to NPAA-containing peptides, we developed a first-generation platform that merges contemporary flavin photocatalysis with parallel synthesis to simultaneously make, purify, quantify, and even test up to 96 single-NPAA peptide variants

Identifiers

PMID34377401
PMCPMC8317666

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.